Search results
Results From The WOW.Com Content Network
The therapeutic recommended dosages were 12.5, 25, and 50 mg with an approximate bioavailability of 93%. [12] [13] [14] Rofecoxib crossed the placenta and blood–brain barrier, [12] [13] [15] and took 1–3 hours to reach peak plasma concentration with an effective half-life (based on steady-state levels) around 17 hours.
Pharmaceutical powerhouse Merck (NYS: MRK) has agreed to settle a class action lawsuit filed in Missouri by Vioxx customers, the company announced yesterday. Those who filed the lawsuit had ...
The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, [ 1 ] and Pfizer’s $2.3 billion ($3.5 billion in 2022) settlement including a record-breaking $1.3 billion criminal fine. [ 2 ]
A fraud investigation by the United States Department of Justice began in 2000 when allegations were brought in two separate lawsuits filed by whistleblowers under the False Claims Act. [188] They alleged that Merck failed to pay proper rebates to Medicaid and other health care programs and paid illegal remuneration to health care providers ...
William Mark Lanier (born October 20, 1960 [1]) is an American trial lawyer and founder and CEO of the Lanier Law Firm. He has led a number of high-profile product litigation suits resulting in billions of dollars in damages, including Johnson & Johnson baby powder and Merck & Co.'s Vioxx drug.
Recently, an $8.85 million settlement was reached in a class action lawsuit filed against Unilever United States, Inc., ... Make sure you submit your completed claim form by Feb. 19, 2025, ...
According to the lawsuit website, the settlement applies to, "All current and former individual consumer account holders in the United States (based on account holders’ last known billing ...
For example, Purdue Pharmaceuticals entered an agreement with the United States, pleading guilty to felony misbranding of OxyContin with intent to defraud and mislead under sections 33 1(a) and 333(a)(2) of the FD&C Act and agreed to pay more than $600 million, but only $160 million was allocated to resolve civil claims under the False Claims ...